Cargando…

TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma

Although the development of mitogen-activated protein kinase (MAPK) inhibitors has greatly improved the prognosis of BRAF(V600) cutaneous melanomas, the identification of molecular indicators for mutated patients at risk of early progression remains a major issue. Using an amplicon-based next-genera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blateau, Pauline, Coyaud, Etienne, Laurent, Estelle, Béganton, Benoit, Ducros, Vincent, Chauchard, Géraldine, Vendrell, Julie A., Solassol, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463448/ https://www.ncbi.nlm.nih.gov/pubmed/32784823 http://dx.doi.org/10.3390/cancers12082224

Ejemplares similares

FKBP4 connects mTORC2 and PI3K to activate the PDK1/Akt-dependent cell proliferation signaling in breast cancer
por: Mangé, Alain, et al.
Publicado: (2019)

Proximal Protein Interaction Landscape of RAS Paralogs
por: Béganton, Benoît, et al.
Publicado: (2020)

Circulating Cell Free Tumor DNA Detection as a Routine Tool for Lung Cancer Patient Management
por: Vendrell, Julie A., et al.
Publicado: (2017)

TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation
por: Vallarelli, Andrelou F., et al.
Publicado: (2016)

Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches
por: Vendrell, Julie A., et al.
Publicado: (2017)

pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma
por: Blanco-García, Leyla, et al.
Publicado: (2023)

Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma
por: MATTILA, Kalle, et al.
Publicado: (2023)

Comparative Methods to Improve the Detection of BRAF V600 Mutations in Highly Pigmented Melanoma Specimens
por: Frouin, Eric, et al.
Publicado: (2016)

Spatial and proteomic profiling reveals centrosome‐independent features of centriolar satellites
por: Gheiratmand, Ladan, et al.
Publicado: (2019)

TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients
por: Del Bianco, Paola, et al.
Publicado: (2020)

EGFR-dependent mechanisms of resistance to osimertinib determined by ctDNA NGS analysis identify patients with better outcome
por: Vendrell, Julie A., et al.
Publicado: (2021)

Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatment
por: Vendrell, Julie A., et al.
Publicado: (2020)

TERT promoter mutations in melanoma survival
por: Nagore, Eduardo, et al.
Publicado: (2019)

TERT Promoter Mutations and Telomerase in Melanoma
por: Guo, Yuchen, et al.
Publicado: (2022)

LUZP1 and the tumor suppressor EPLIN modulate actin stability to restrict primary cilia formation
por: Gonçalves, João, et al.
Publicado: (2020)

ifCNV: A novel isolation-forest-based package to detect copy-number variations from various targeted NGS datasets
por: Cabello-Aguilar, Simon, et al.
Publicado: (2022)

PPP1R35 is a novel centrosomal protein that regulates centriole length in concert with the microcephaly protein RTTN
por: Sydor, Andrew Michael, et al.
Publicado: (2018)

Determination of the Optimal Bacterial DNA Extraction Method to Explore the Urinary Microbiota
por: Vendrell, Julie A., et al.
Publicado: (2022)

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma
por: Paulsson, Johan O., et al.
Publicado: (2018)

Germline TERT promoter mutations are rare in familial melanoma
por: Harland, Mark, et al.
Publicado: (2015)

Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer
por: Yang, Hui, et al.
Publicado: (2017)

FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer
por: Tang, Qingyun, et al.
Publicado: (2022)

TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk
por: Osella-Abate, Simona, et al.
Publicado: (2019)

Case report: Liquid biopsy, the sooner the better?
por: Thomas, Quentin Dominique, et al.
Publicado: (2022)

TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma
por: Kikuchi, Zensho, et al.
Publicado: (2020)

Is There an Independent Role of TERT and NF1 in High Grade Gliomas?
por: Razis, Evangelia, et al.
Publicado: (2019)

Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer
por: Vendrell, Julie A., et al.
Publicado: (2019)

Cutaneous Epithelial Tumors Induced by Vemurafenib Involve the MAPK and Pi3KCA Pathways but Not HPV nor HPyV Viral Infection
por: Frouin, Eric, et al.
Publicado: (2014)

Alternative proteins are functional regulators in cell reprogramming by PKA activation
por: Cardon, Tristan, et al.
Publicado: (2020)

The MAPK pathway as an apoptosis enhancer in melanoma
por: Haydn, Johannes M., et al.
Publicado: (2014)

Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
por: Reyes-Uribe, Patricia, et al.
Publicado: (2018)

Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma
por: Liang, Winnie S., et al.
Publicado: (2017)

Overexpression of RACK1 Predicts Poor Prognosis in Melanoma
por: Shen, Congcong, et al.
Publicado: (2020)

hTERT promotes cell adhesion and migration independent of telomerase activity
por: Liu, Haiying, et al.
Publicado: (2016)

Differential Sensitivity of Germline and Somatic BRCA Variants to PARP Inhibitor in High-Grade Serous Ovarian Cancer
por: Vendrell, Julie A., et al.
Publicado: (2023)

Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors
por: Khamari, Raeeka, et al.
Publicado: (2018)

Haploinsufficiency of RREB1 causes a Noonan-like RASopathy via epigenetic reprogramming of RAS-MAPK pathway genes
por: Kent, Oliver A., et al.
Publicado: (2020)

TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
por: Griewank, K G, et al.
Publicado: (2013)

ETS1, nucleolar and non-nucleolar TERT expression in nevus to melanoma progression
por: Kohli, Jaskaren S., et al.
Publicado: (2017)

Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis
por: van Poppelen, Natasha M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3di22cslvrrf4tic5tog0jtjcd